ITTO940543A0 - Materiale proteico ricombinante legante anticorpi contro il citomega- lovirus umano, reagenti diagnostici derivati da tale materiale protei-co e plasmide ricombinante esprimente lo stesso. - Google Patents

Materiale proteico ricombinante legante anticorpi contro il citomega- lovirus umano, reagenti diagnostici derivati da tale materiale protei-co e plasmide ricombinante esprimente lo stesso.

Info

Publication number
ITTO940543A0
ITTO940543A0 ITTO940543A ITTO940543A ITTO940543A0 IT TO940543 A0 ITTO940543 A0 IT TO940543A0 IT TO940543 A ITTO940543 A IT TO940543A IT TO940543 A ITTO940543 A IT TO940543A IT TO940543 A0 ITTO940543 A0 IT TO940543A0
Authority
IT
Italy
Prior art keywords
protein material
recombinant
same
antibody against
binding antibody
Prior art date
Application number
ITTO940543A
Other languages
English (en)
Inventor
Alessandro Ripalti
Maria Paola Landini
Original Assignee
Maria Paola Landini
Alessandro Ripalti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maria Paola Landini, Alessandro Ripalti filed Critical Maria Paola Landini
Publication of ITTO940543A0 publication Critical patent/ITTO940543A0/it
Priority to IT94TO000543A priority Critical patent/IT1266740B1/it
Priority to US08/765,856 priority patent/US6074817A/en
Priority to ES95918148T priority patent/ES2232821T3/es
Priority to PCT/IT1995/000073 priority patent/WO1996001321A1/en
Priority to AU24188/95A priority patent/AU2418895A/en
Priority to EP95918148A priority patent/EP0769057B1/en
Priority to DE69533442T priority patent/DE69533442T2/de
Priority to CA002194135A priority patent/CA2194135C/en
Priority to AT95918148T priority patent/ATE275201T1/de
Priority to JP50377396A priority patent/JP3907204B2/ja
Publication of ITTO940543A1 publication Critical patent/ITTO940543A1/it
Application granted granted Critical
Publication of IT1266740B1 publication Critical patent/IT1266740B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IT94TO000543A 1994-07-01 1994-07-01 Materiale proteico ricombinante legante anticorpi contro il citomegalovirus umano, reagenti diagnostici derivati da tale IT1266740B1 (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT94TO000543A IT1266740B1 (it) 1994-07-01 1994-07-01 Materiale proteico ricombinante legante anticorpi contro il citomegalovirus umano, reagenti diagnostici derivati da tale
AU24188/95A AU2418895A (en) 1994-07-01 1995-05-15 Recombinant mono and poly antigens to detect cytomegalovirus-specific igm in human sera by enzyme immunoassay
ES95918148T ES2232821T3 (es) 1994-07-01 1995-05-15 Mono- y poli-antigenos recombinados para la deteccion del igm especifico del citomegalovirus en los sueros humanos por dosificado inmuno-enzimatico.
PCT/IT1995/000073 WO1996001321A1 (en) 1994-07-01 1995-05-15 RECOMBINANT MONO AND POLY ANTIGENS TO DETECT CYTOMEGALOVIRUS-SPECIFIC IgM IN HUMAN SERA BY ENZYME IMMUNOASSAY
US08/765,856 US6074817A (en) 1994-07-01 1995-05-15 Recombinant mono and poly antigens to detect cytomegalovirus-specific IgM in human sera by enzyme immunoassay
EP95918148A EP0769057B1 (en) 1994-07-01 1995-05-15 RECOMBINANT MONO AND POLY ANTIGENS TO DETECT CYTOMEGALOVIRUS-SPECIFIC IgM IN HUMAN SERA BY ENZYME IMMUNOASSAY
DE69533442T DE69533442T2 (de) 1994-07-01 1995-05-15 Rekombinante Mono- und Polyantigene zum Nachweis von Cytomegalievierus-spezifischen IgM mittels Enzymimmunotests
CA002194135A CA2194135C (en) 1994-07-01 1995-05-15 Recombinant mono and poly antigens to detect cytomegalovirus-specific igm in human sera by enzyme immunoassay
AT95918148T ATE275201T1 (de) 1994-07-01 1995-05-15 Rekombinante mono- und polyantigene zum nachweis von cytomegalovirus-spezifischen igm mittels enzymimmunotesten
JP50377396A JP3907204B2 (ja) 1994-07-01 1995-05-15 酵素的イムノアッセイにより人血清中のサイトメガロウイルス特異的ＩｇＭを検出するための組換えモノおよびポリ抗原

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT94TO000543A IT1266740B1 (it) 1994-07-01 1994-07-01 Materiale proteico ricombinante legante anticorpi contro il citomegalovirus umano, reagenti diagnostici derivati da tale

Publications (3)

Publication Number Publication Date
ITTO940543A0 true ITTO940543A0 (it) 1994-07-01
ITTO940543A1 ITTO940543A1 (it) 1996-01-01
IT1266740B1 IT1266740B1 (it) 1997-01-14

Family

ID=11412643

Family Applications (1)

Application Number Title Priority Date Filing Date
IT94TO000543A IT1266740B1 (it) 1994-07-01 1994-07-01 Materiale proteico ricombinante legante anticorpi contro il citomegalovirus umano, reagenti diagnostici derivati da tale

Country Status (9)

Country Link
US (1) US6074817A (it)
EP (1) EP0769057B1 (it)
JP (1) JP3907204B2 (it)
AT (1) ATE275201T1 (it)
AU (1) AU2418895A (it)
DE (1) DE69533442T2 (it)
ES (1) ES2232821T3 (it)
IT (1) IT1266740B1 (it)
WO (1) WO1996001321A1 (it)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0702083A3 (de) * 1994-07-26 1997-01-15 Biotest Ag Polypeptide und Fusionsproteine bestehend aus dem UL 57 Leserahmen bzw. dem C-terminalen Bereich des Tegumentproteins pp150 aus HCMV, entsprechende Oligonucleotide und Nachweis reagentien
DE69637659D1 (de) * 1995-05-15 2008-10-09 Abbott Lab Verankerte expression heterologer proteine
US5800981A (en) * 1996-02-22 1998-09-01 University Of Limburg Human cytomegalovirus antigen and its use
US6448389B1 (en) 1996-04-23 2002-09-10 The Wistar Institute Of Anatomy And Biology Human cytomegalovirus DNA constructs and uses therefor
US7901910B2 (en) 1996-05-14 2011-03-08 Gregory Thomas Maine Embedded expression of insoluble heterologous proteins
DK0960336T3 (da) * 1996-07-12 2003-02-10 Organon Teknika Bv Peptidreagens til påvisning af humant cytomelagovirus (CMV)
IT1290804B1 (it) * 1996-08-16 1998-12-11 Abbott Lab Saggio western blot perfezionato per l'individuazione di anticorpi specifici contro il virus hcmv
FR2757169B1 (fr) * 1996-12-13 1999-03-05 Inst Nat Sante Rech Med Proteine de fusion comportant tout ou partie de la proteine pp65 de cmv humain, utile notamment dans la preparation d'un vaccin
US6177241B1 (en) * 1997-09-22 2001-01-23 Abbott Laboratories Use of peptides to improve specificity of an immunoassay for the detection of cytomegalovirus specific IgM antibody
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
AUPR593101A0 (en) * 2001-06-26 2001-07-19 Council Of The Queensland Institute Of Medical Research, The Cytomegalovirus t cell epitopes
MXPA04005382A (es) * 2001-11-07 2005-02-24 Mannkind Corp Vectores de expresion que codifican epitopes de antigenos asociados al objetivo y metodos para su diseno.
EP1460426A1 (en) * 2003-03-20 2004-09-22 Sysmex Corporation Method for detecting antibody against BDV (Borna disease virus) for detecting a BDV infection
WO2005014627A1 (en) * 2003-08-07 2005-02-17 International Centre For Genetic Engineering And Biotechnology Recombinant dengue multi epitope proteins as diagnostic intermediates
US7432046B2 (en) * 2005-11-02 2008-10-07 Abbott Laboratories Methods for the determination of antibody IgG avidity
AU2008279584A1 (en) * 2007-04-27 2009-01-29 Dow Global Technologies Inc. Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles
EP2152890A1 (en) * 2007-05-23 2010-02-17 MannKind Corporation Multicistronic vectors and methods for their design
KR101919330B1 (ko) * 2011-06-16 2018-11-19 후지필름 가부시키가이샤 고감도의 면역크로마토그래프 방법 및 면역크로마토그래프용 키트
CN104569387B (zh) * 2015-01-13 2017-06-16 必欧瀚生物技术（合肥）有限公司 一种ELISA检测人血清HCMV pp150 IgM抗体试剂盒
US10309964B2 (en) 2015-02-09 2019-06-04 Xiamen University Method for assessing risk of human cytomegalovirus active infection in body and related kit

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6376192A (ja) * 1986-09-19 1988-04-06 Fujitsu Ltd 半導体記憶装置
US5124255A (en) * 1988-03-11 1992-06-23 Abbott Laboratories CKS method of protein synthesis
US5244630A (en) * 1988-04-22 1993-09-14 Abbott Laboratories Device for performing solid-phase diagnostic assay
US5268273A (en) * 1990-12-14 1993-12-07 Phillips Petroleum Company Pichia pastoris acid phosphatase gene, gene regions, signal sequence and expression vectors comprising same
DE4128684A1 (de) * 1991-08-29 1993-03-04 Behringwerke Ag Hcmv-spezifische peptide, mittel dazu und ihre verwendung

Also Published As

Publication number Publication date
US6074817A (en) 2000-06-13
WO1996001321A1 (en) 1996-01-18
JP3907204B2 (ja) 2007-04-18
ATE275201T1 (de) 2004-09-15
DE69533442D1 (de) 2004-10-07
JPH10502253A (ja) 1998-03-03
ITTO940543A1 (it) 1996-01-01
AU2418895A (en) 1996-01-25
EP0769057A1 (en) 1997-04-23
EP0769057B1 (en) 2004-09-01
IT1266740B1 (it) 1997-01-14
ES2232821T3 (es) 2005-06-01
DE69533442T2 (de) 2005-09-22

Similar Documents

Publication Publication Date Title
NO970617D0 (no) Laminert komposittmateriale, dets fremstilling og produkter inneholdende materialet
AU5671594A (en) Human tissue factor related dna segments, polypeptides and antibodies
DE69628791D1 (de) Absorbierende Zusammensetzung, absorbierendes Material, und ein, das absorbierende Material enthaltende, absorbierendes Produkt.
ZA947122B (en) Drug binding protein.
TR199600084A2 (tr) Sismanlamaya karsi proteinler.
FI940909A7 (fi) Lyofilisoituja polyalkyleenioksidimodifioituja proteiini- ja polypeptidikomplekseja, joissa on syklodekstriiniä
AU1332099A (en) Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use
EP0711303A4 (en) BIOTINYLATION OF PROTEINS
DE68914835D1 (de) Proteinerzeugnisse.
FI922454A7 (fi) Peptidit ja vasta-aineet, jotka inhiboivat intergriiniligandin sitoutu mista
ZA9610721B (en) Grapevine leafroll virus proteins and their uses.
BR9106108A (pt) Recuperacao de proteina,isolado de proteinas e/ou amido de grao de cereais
DE69526022D1 (de) Elastisches, eingeschnürt gebundenes Verbundmaterial
EP0973893A4 (en) INTRACELLULAR, AMYLOID-BETA-BINDING POLYPEPTIDES (ERAB).
AU8947791A (en) Glycosaminoglycan-targeted fusion proteins, their design, construction and compositions
DE68921971D1 (de) Komposit-Ferrit-Material.
DE68911498D1 (de) Polypeptide, isoliert aus dem Gift von Hololena curta.
DE69634489D1 (de) Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon
IT1304596B1 (it) Materiale con radiazione nell'infrarosso lontano e medicinale e ciboderivati dallo stesso.
AU4606196A (en) Assay, receptor proteins and ligands
AU3186397A (en) Prion protein binding proteins and uses thereof
DE3888162D1 (de) Sehr dünner und hochfester Draht und Verstärkungsmaterial und Verbundmaterial enthaltend diesen Draht.
NO952109D0 (no) Komposittmateriale
ITTO911019A0 (it) Materiale proteico ricombinante legante anticorpi contro il cigalomegavirus umano, reagenti diagnostici derivati da tale materialeproteico e plasmide ricombinante esprimente lo stesso.
IL110954A0 (en) Pharmaceutical compositions comprising a retinoblastoma polypeptide or protein, and methods for the preparation and use thereof

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970729